Isotopia Molecular Imaging Ltd Sustainability Profile
Isotopia Molecular Imaging Ltd., a leading name in the field of molecular imaging, is headquartered in Israel (IL) and operates extensively across Europe and North America. Founded in 2006, the company has established itself as a pioneer in the development of innovative radiopharmaceuticals and imaging agents, catering primarily to the medical and research sectors. Isotopia's core offerings include a range of high-quality radiotracers and diagnostic imaging solutions that enhance the accuracy of disease detection and treatment monitoring. What sets Isotopia apart is its commitment to quality and compliance with stringent regulatory standards, ensuring that its products meet the highest industry benchmarks. With a strong market position, Isotopia has achieved significant milestones, including collaborations with leading healthcare institutions, solidifying its reputation as a trusted partner in molecular imaging.
DitchCarbon Score
How does Isotopia Molecular Imaging Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Isotopia Molecular Imaging Ltd's score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Isotopia Molecular Imaging Ltd's reported carbon emissions
Isotopia Molecular Imaging Ltd, headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Isotopia may not yet have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. As the industry increasingly prioritises climate action, it will be essential for Isotopia to consider developing measurable targets and strategies to align with global climate goals.
How Carbon Intensive is Isotopia Molecular Imaging Ltd's Industry?
How Carbon Intensive is Isotopia Molecular Imaging Ltd's Location?
Isotopia Molecular Imaging Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Isotopia Molecular Imaging Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
